GAP analysis and SWOT analysis of pharmacopoeial quality standards of Calendulae flos: experience of Ukraine and France
DOI:
https://doi.org/10.5281/zenodo.17923205Keywords:
Calendula officinalis, calendula flowers, State Pharmacopoeia of Ukraine, Pharmacopée française, standardization, quality of medicinal plant raw materials, GAP analysis, SWOT analysis, harmonization of pharmacopoeiasAbstract
The article considers the issue of harmonization of requirements for standardization of medicinal plant raw materials using the example of Calendula officinalis flowers in the context of the State Pharmacopoeia of Ukraine and the Pharmacopée française. Introduction. The relevance of the topic is substantiated in connection with the need to improve the quality, safety, and competitiveness of domestic herbal medicines, as well as the integration of Ukraine into the European pharmacopoeial space. Purpose. The purpose of the study was to conduct a comparative analysis of the requirements of the State Pharmacopoeia of Ukraine and the Pharmacopée française for Calendulae flos, identify the strengths and weaknesses of domestic regulation and formulate recommendations for harmonization with European standards. Materials and methods. Methods of comparative analysis of regulatory documents, GAP (Gap Analysis Process), and SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses were used to identify differences and similarities in the requirements for identification, purity, and quantification of marker substances. Additionally, data from the European Pharmacopoeia, the World Health Organization and the European Medicines Agency were used as a reference base. Results and discussion. Shown that the State Pharmacopoeia of Ukraine contains basic requirements for macro- and microscopic characteristics, thin-layer chromatography and purity indicators, but less detailed identification tests, a limited list of purity indicators and a narrower approach to quantification compared to the Pharmacopée française. The French Pharmacopoeia, unlike the Ukrainian one, focuses on specific marker compounds (flavonoids, carotenoids), control of impurities (including pesticides and heavy metals) and modern methods of analysis. SWOT analysis revealed the strengths of both systems, but showed the need to improve domestic standards. Conclusions. The analysis confirmed that the harmonization of the State Pharmacopoeia of Ukraine with the Pharmacopée française and the European Pharmacopoeia is an important condition for increasing the level of standardization of medicinal plant raw materials in Ukraine. The introduction of modern identification methods, expanding the list of marker substances and purity indicators will help guarantee the safety and effectiveness of medicinal products of herbal origin, and will also strengthen the competitive position of domestic products on the international market.
References
State Pharmacopoeia of Ukraine. Supplement 5.1. Kharkiv: State Enterprise "Ukrainian Scientific Pharmacopoeial Center for the Quality Medicines", 2022. 732 p.URL: https://srumpl.org/SPU.html
Pharmacopée Française. 12ᵉ édition. Paris: Agence nationale de sécurité du médicament et des produits de santé (ANSM), 2022. URL: https://www.edqm.eu/fr/european-pharmacopoeia-new-online-only-12th-edition
Preethi K.C., Kuttan G. Wound healing activity of flower extract of Calendula officinalis. Journal of Basic and Clinical Physiology and Pharmacology. 2009. Vol. 20. Iss. 1. P. 73–79. DOI: https://doi.org/10.1515/JBCPP.2009.20.1.73.
European Pharmacopoeia. 11ᵗʰ edition. Strasbourg: Council of Europe, European Directorate for the Quality of Medicines & HealthCare (EDQM), 2023. URL: https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition
WHO Monographs on Selected Medicinal Plants. Volume 4. Geneva: World Health Organization, 2009. P. 289. URL: https://www.e-lactancia.org/media/papers/Fitoterapia-WHO-01.pdf
ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition, supplement. Stuttgart: Thieme, 2009. URL: https://www.escop.com/escop-products/publications/
European Medicines Agency. Assessment report on Calendula officinalis L., flos. EMA/HMPC/245819/2014. London: EMA, 2014. URL: https://www.ema.europa.eu/en/medicines/herbal/calendulae-flos
Muley B.P., Khadabadi S.S., Banarase N.B. Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): a review. Tropical Journal of Pharmaceutical Research. 2009. Vol. 8. Iss. 5. P. 455–465. DOI: https://doi.org/10.4314/tjpr.v8i5.48090.
Bilia A.R., Escudero Rubio M. del Mar, Ladero Alvarez M., Morelli I., Muñoz Gonzalez J. New Benzyl Alcohol Glycosides from Pyrus bourgaeana. Planta Medica. 1994. Vol. 60. Iss. 6. P. 569–571. DOI: https://doi.org/10.1055/s-2006-959574.
Silva C.J., Takahashi C.S., Bastos J.K. Evaluation of the genotoxic and cytotoxic effects of crude extracts of Cordia ecalyculata and Echinodorus grandiflorus. Journal of Ethnopharmacology. 2010. Vol. 127. Iss. 2. P. 445–450. DOI: https://doi.org/10.1016/j.jep.2009.10.015.
Barnes J., Anderson L.A., Phillipson J.D. Herbal Medicines. 4th ed. Pharmaceutical Press. London, 2013. 710 p. URL: https://drhazhan.com/Barnes%20-%20Herbal%20Medicines%20(Pharmaceutical%20Press,%202007).pdf
Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. 2nd ed. Paris: Lavoisier, 1999. 1119 p. URL: https://www.scirp.org/reference/referencespapers?referenceid=1527238
Heinrich M., Barnes J., Gibbons S., Williamson E. Fundamentals of Pharmacognosy and Phytotherapy. 3rd ed. Elsevier, 2018. 352 p. URL: https://shop.elsevier.com/books/fundamentals-of-pharmacognosy-and-phytotherapy/heinrich/978-0-7020-7008-2
Tistaert C., Dejaegher B., Vander Heyden Y. Chromatographic separation techniques and data handling methods for herbal fingerprints: a review. Anal Chim Acta. 2011. Vol. 690. Iss. 2. P. 148–161. DOI: https://doi.org/10.1016/j.aca.2011.02.023
Jiang Y., David B., Tu P., Barbin Y. Recent analytical approaches in quality control of traditional Chinese medicines—A review. Anal Chim Acta. 2010. Vol. 657. Iss. 1. P. 9–18. DOI: https://doi.org/10.1016/j.aca.2009.10.024
Krief A., Dunkle M., Bahar M., Bultinck P., Herrebout W., Sandra P. Elucidation of the absolute configuration of rhizopine by chiral supercritical fluid chromatography and vibrational circular dichroism. Journal of Separation Science. 2015. Vol. 38. Iss. 11. P. 1801–1807. DOI: https://doi.org/10.1002/jssc.201500138.
Mukherjee P.K. Quality control of herbal drugs: An approach to evaluation of botanicals. Business Horizons. New Delhi: 2002. 800 p. URL: https://www.researchgate.net/publication/285479791_Quality_Control_of_Herbal_Drugs_An_Approach_to_Evaluation_of_Botanicals
Pasrija P., Girdhar M., Kumar M., Arora S., Katyal A. Endophytes: an unexplored treasure to combat Multidrug resistance. Phytomedicine Plus. 2022. Vol. 2, Iss. 2, Article 100249. DOI: https://doi.org/10.1016/j.phyplu.2022.100249
Lv, M., Wang, Y., Qu, P., Li, S., Yu, Z., Qin, X., & Liu, X. (2021). A combination of cecum microbiome and metabolome in CUMS depressed rats reveals the antidepressant mechanism of traditional Chinese medicines: A case study of Xiaoyaosan. Journal of Ethnopharmacology, 276, 114167. DOI: https://doi.org/10.1016/j.jep.2021.114167
Cos P., Vlietinck A.J., Berghe D.V., Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’. J Ethnopharmacol. 2006. Vol. 106. Iss. 3. P. 290–302. DOI: https://doi.org/10.1016/j.jep.2006.04.003
Gao, R., Guan, N., Huang, M., Foreman, J., Kung, M., Rong, Z., Su, Y., Sweet, L., Zhu, B., Zhu, H., Zou, H., Li, B., Wang, Y., Yin, H., Yin, Z., & Zhang, X. Read-across: Principle, case study and its potential regulatory application in China. Regulatory Toxicology and Pharmacology. 2020. Vol. 116. № 104728. DOI: https://doi.org/10.1016/j.yrtph.2020.104728
European Directorate for the Quality of Medicines & HealthCare (EDQM). European Pharmacopoeia, 11th Edition. Strasbourg: Council of Europe; 2023. URL: https://www.edqm.eu
United States Pharmacopeia (USP 46 – NF 41). The United States Pharmacopeial Convention. Rockville, MD; 2023. URL: https://www.uspnf.com
World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: WHO, 2007. URL: https://apps.who.int/iris/handle/10665/43510
EMA. Guideline on quality of herbal medicinal products/traditional herbal medicinal products. European Medicines Agency, 2011. URL: https://www.ema.europa.eu
Nevzghoda O., Osyntseva A., Shapovalov V., Shapovalova V., Veits O. Antitussive codeine medicines in Ukraine: clinical and pharmacological, marketing, regulatory aspects, and forecasts. Annals of Mechnikov’s Institute. 2025. No.1. P.33–45. DOI: https://doi.org/10.5281/zenodo.1501181293
Shapovalova V. Human Metapneumovirus: Modern Challenges for Medicine and Pharmaceutics. SSP Modern Pharmacy and Medicine. 2025. Vol. 5. No. 2. P. 1-14. DOI: https://doi.org/10.53933/sspmpm.v5i2.180
Shapovalova V. Telemedicine and Telepharmacy in Modern Healthcare: Innovations, Medical Technologies, Digital Transformation. SSP Modern Pharmacy and Medicine. 2025. Vol.5. Iss. 3. P.1-19. DOI: https://doi.org/10.53933/r7f5xj91
Nevzghoda O., Osyntseva A., Shapovalova V., Titarenko I., Shapovalov V., Dovzhuk V., Shapovalov V. Optimization of pharmacotherapy for chronic pancreatitis: use of ABC/VED analysis in marketing and pharmacoeconomic studies. Proceedings of Shevchenko Scientific Society Medical Sciences. 2025. Vol. 77. Iss. 1. P. 1-14. DOI: https://doi.org/10.25040/ntsh2025.01.16. URL: https://mspsss.org.ua/index.php/journal/article/view/1125
Shapovalov V., Shapovalova V., Titarenko I., Osyntseva A., Shapovalov V. Quantum medicine and pharmacotherapy of chronic pancreatitis: analysis of drugs and international experience of microwave resonance therapy. Revista Colombiana de Ciencias Químico-Farmacéuticas. 2025. Vol. 54. No. 2. P. 220–244. DOI: https://doi.org/10.15446/rcciquifa.v54n2.117235. URL: https://revistas.unal.edu.co/index.php/rccquifa/article/view/117235
Nevzghoda O., Osyntseva A., Shapovalov V., Titarenko I., Dovzhuk V., Shapovalova V., Shapovalov V. Content analysis of combined anti-tuberculosis drugs. Annals of Mechnikov’s Institute. 2025. No.2. P. 31–38. DOI: https://doi.org/10.5281/zenodo.15662640
Shapovalov V., Veits O., Lavoshnyk O., Gubaryeva O. Modern Pharmaceutical Law, Administration and Corporate Terms in Pharmaceutical and Healthcare Industries for Corruption-Free Circulation of Vaccines. SSP Modern Economics, State and Public Administration. 2025. Vol. 4. No. 1. P. 1-19. DOI: https://doi.org/10.53933/40rgye75
Osyntseva A. Current Trends in Tuberculosis Pharmacotherapy: Availability of Essential Medicines. SSP Modern Pharmacy and Medicine. 2025. Vol.5. No.2. P.1–14. DOI: https://doi.org/10.53933/sspmpm.v5i2.188
Nevzghoda O.A., Shapovalov V.V., Shapovalova V.O., Osyntseva A.O., Shapovalov V.V., Protsiuk R.H. Optimisation of antibiotic selection: ABC and VED analysis of medicines against intracellular microorganisms. Tuberculosis, Pulmonary Diseases, HIV-infection. 2025. No. 3 (62). P. 68–79. DOI: http://doi.org/10.30978/TB2025-3-68. URL: http://tubvil.com.ua/article/view/336295
Osintseva A., Shapovalova V. Marketing positioning strategies for group B vitamins in the anti-tuberculosis pharmacotherapy niche. In: Osyka V. (ed.). Entrepreneurship, trade, marketing: strategies, technologies and innovations. Proceedings of the 8th International Scientific and Practical Internet Conference (Kyiv, May 21, 2025). Kyiv: State University of Trade and Economics. 2025. P. 276–280. DOI: https://doi.org/10.31617/k.knute.2025-05-21
Nevzghoda, O., Shapovalov, V., Osintseva, A., Shapovalova, V., Shapovalov, V. Pharmacoeconomic studies of the feasibility of using certain groups of drugs in diseases of the chest organs. Scientific Research Establishment of Innovations for Future LLC. 2025. 46 p. DOI: https://doi.org/10.53933/zb6y1w26. URL: Pharmacoeconomic Studies of the Feasibility of Using Certain Groups of Drugs in Diseases of the Chest Organs | Scientific Research Establishment of Innovations for Future LLC
Nevzghoda O. Pharmacoeconomic rationale for the use of drugs for maintenance therapy in pulmonology. In: Pharmacoeconomic Studies of the Feasibility of Using Certain Groups of Drugs in Diseases of the Chest Organs. Scientific Research Establishment of Innovations for Future LLC. 2025. P. 9-20. DOI: https://doi.org/10.53933/zb6y1w26 URL: PDF view of the file Book11092025.pdf
Osyntseva A. Pharmacoeconomic evaluation of adjuvant and pathogenetic therapy in patients with pulmonary infections and pulmonary hypertension. In: Pharmacoeconomic Studies of the Feasibility of Using Certain Groups of Drugs in Diseases of the Chest Organs. Scientific Research Establishment of Innovations for Future LLC. 2025. P. 21-32. DOI: https://doi.org/10.53933/zb6y1w26 URL: PDF view of the file Book11092025.pdf
Shapovalov V. Practical recommendations for implementing ABC/VED analysis in healthcare facilities. In: Pharmacoeconomic Studies of the Feasibility of Using Certain Groups of Drugs in Diseases of the Chest Organs. Scientific Research Establishment of Innovations for Future LLC. 2025. P. 33-34. DOI: https://doi.org/10.53933/zb6y1w26 URL: PDF view of the file Book11092025.pdf
Shapovalov V. Multidisciplinary study of risks in pulmonology in the system of legal relations "doctor-patient-pharmacist-lawyer. In: Pharmacoeconomic Studies of the Feasibility of Using Certain Groups of Drugs in Diseases of the Chest Organs. Scientific Research Establishment of Innovations for Future LLC. 2025. P. 35-39. DOI: https://doi.org/10.53933/zb6y1w26 URL: PDF view of the file Book11092025.pdf
Nevzghoda O., Shapovalov V., Osyntseva A., Shapovalova V., Shapovalov V. Pleural empyema and exudative pleurisy: clinical experience, an integrated approach to evidence. Annals of Mechnikov’s Institute. 2025. Iss. 3. P. 63–80. DOI: https://doi.org/10.5281/zenodo.17105671. URL: https://journals.uran.ua/ami/article/view/337072
Shapovalova V. Morgellons disease as a multisystem problem: аnalysis of hypotheses, scientific evidence, how аrtificial іntelligence helps. SSP Modern Pharmacy and Medicine. 2025. Vol.5. Iss.4. P.1-14. DOI: https://doi.org/10.53933/fxbnwe45
Nevzghoda O., Shapovalova V. Methodology of diagnosis and treatment of sail-like adhesions in еxudative рleuritis using thoracoscopy and video-аssisted thoracoscopy. Informative letter (Report). DOI: https://doi.org/10.53933/t2svps51
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Annals of Mechnikov's Institute
This work is licensed under a Creative Commons Attribution 4.0 International License.
